{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:55:11Z","timestamp":1790243711848,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ziarco Pharma"},{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jaci.2018.07.047","type":"journal-article","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T20:05:22Z","timestamp":1541707522000},"page":"1830-1837.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":126,"title":["Efficacy and safety of the histamine H4 receptor antagonist ZPL-3893787 in patients with atopic dermatitis"],"prefix":"10.1016","volume":"143","author":[{"given":"Thomas","family":"Werfel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Layton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Yeadon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndsey","family":"Whitlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Osterloh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliya","family":"Asher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Tsianakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Purkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl\u00a04","key":"10.1016\/j.jaci.2018.07.047_bib1","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jaci.2017.01.009","article-title":"Current guidelines for the evaluation and management of atopic dermatitis: a\u00a0comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines","volume":"139","author":"Eichenfield","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.07.047_bib2","first-page":"92","article-title":"S2k guideline on diagnosis and treatment of atopic dermatitis","volume":"14","author":"Werfel","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaci.2018.07.047_bib3","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/archdermatol.2011.178","article-title":"The impact of pruritus on quality of life: the skin equivalent of pain","volume":"147","author":"Kini","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2018.07.047_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jaci.2006.04.043","article-title":"How epidemiology has challenged 3 prevailing concepts about atopic dermatitis","volume":"118","author":"Williams","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.07.047_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaci.2018.07.047_bib6","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"375","author":"Simpson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2018.07.047_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fphar.2015.00065","article-title":"The histamine H4 receptor: from orphan to the clinic","volume":"6","author":"Thurmond","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaci.2018.07.047_bib9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaci.2006.08.034","article-title":"Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus","volume":"119","author":"Dunford","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.07.047_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/1346-8138.12726","article-title":"Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis","volume":"42","author":"Murata","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2018.07.047_bib11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1124\/pr.114.010249","article-title":"International union of basic and clinical pharmacology. XCVIII. Histamine receptors","volume":"67","author":"Panula","year":"2015","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jaci.2018.07.047_bib12","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.drudis.2014.05.007","article-title":"Histamine H4 receptor antagonists for the treatment of inflammatory disorders","volume":"19","author":"Liu","year":"2014","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jaci.2018.07.047_bib13","doi-asserted-by":"crossref","first-page":"6596","DOI":"10.1016\/j.bmcl.2011.07.125","article-title":"Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: a novel histamine H4 receptor antagonist","volume":"21","author":"Mowbray","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jaci.2018.07.047_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-0625.2001.100102.x","article-title":"The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group","volume":"10","author":"Hanifin","year":"2001","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2018.07.047_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000247298","article-title":"Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis","volume":"186","year":"1993","journal-title":"Dermatol"},{"key":"10.1016\/j.jaci.2018.07.047_bib16","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jaci.2016.06.010","article-title":"Cellular and molecular immunologic mechanisms in patients with atopic dermatitis","volume":"138","author":"Werfel","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.07.047_bib17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaci.2008.12.1110","article-title":"The histamine H4 receptor is functionally expressed on T(H)2 cells","volume":"123","author":"Gutzmer","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.07.047_bib18","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/sj.jid.5701250","article-title":"Human inflammatory dendritic epidermal cells express a functional histamine H4 receptor","volume":"128","author":"Dijkstra","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2018.07.047_bib19","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.4049\/jimmunol.174.9.5224","article-title":"Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells","volume":"174","author":"Gutzmer","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2018.07.047_bib20","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jaci.2013.06.023","article-title":"Histamine induces proliferation in keratinocytes from patients with atopic dermatitis through the histamine 4 receptor","volume":"132","author":"Glatzer","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.07.047_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.phrs.2016.08.001","article-title":"Stimulation of the histamine 4 receptor upregulates thymic stromal lymphopoietin\u00a0(TSLP) in human and murine keratinocytes","volume":"113","author":"Schaper","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jaci.2018.07.047_bib22","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1523\/JNEUROSCI.23-15-06176.2003","article-title":"Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin","volume":"23","author":"Steinhoff","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.jaci.2018.07.047_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/all.12779","article-title":"Histamine H4 receptor knockout mice display reduced inflammation in a chronic model of atopic dermatitis","volume":"71","author":"Rossbach","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.07.047_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-0625.2008.00762.x","article-title":"Histamine H4 receptor antagonism reduces hapten-induced scratching behaviour but not inflammation","volume":"18","author":"Rossbach","year":"2009","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2018.07.047_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/jpet.114.215749","article-title":"The histamine H4 receptor antagonist, JNJ 39758979, is effective in reducing histamine-induced pruritus in a randomized clinical study in healthy subjects","volume":"350","author":"Kollmeier","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaci.2018.07.047_bib26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2340\/00015555-1360","article-title":"Relieving the pruritus of atopic dermatitis: a meta-analysis","volume":"92","author":"Sher","year":"2012","journal-title":"Acta Derm Venereol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918315781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918315781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:19:43Z","timestamp":1758791983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674918315781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0091674918315781"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2018.07.047","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734417901.793554655","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of the histamine H4 receptor antagonist ZPL-3893787 in patients with atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2018.07.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}